Screening for Cerebral Metastases with FDG PET in Patients Undergoing Whole-Body Staging of Non–Central Nervous System Malignancy-Reference-Cited by-同舟云学术

Screening for Cerebral Metastases with FDG PET in Patients Undergoing Whole-Body Staging of Non–Central Nervous System Malignancy

Published:2003-01 Issue:1 Volume:226 Page:181-187
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Rohren Eric M.,Provenzale James M.,Barboriak Daniel P.,Coleman R. Edward

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2261010920

Reference13 articles.

1. Clinical PET in Oncology

2. Relevance of Positron Emission Tomography (PET) in Oncology

3. Introduction to Imaging Brain Tumor Metabolism with Positron Emission Tomography (PET)

4. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC.Clinical applications of PET for the evaluation of brain tumors.J Nucl Med1991; 32:616-622.

5. Coleman RE, Tesar R, Phelps M.HCFA and expanded coverage of PET.J Nucl Med2001; 42:11N-12N.

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron emission tomography–computed tomography vs. brain magnetic resonance imaging for the detection of cerebral metastases of melanoma: a 5-year retrospective study;Clinical and Experimental Dermatology;2024-04-16

2. Brain metastasis resection: the impact of fluorescence guidance (MetResect study);Neurosurgical Focus;2023-08

3. The diagnostic performance of 18fluorine-fluorodeoxyglucose PET for brain metastases: a systematic review and meta-analysis;Nuclear Medicine Communications;2023-06-05

4. Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives;Cancer Imaging;2023-05-31

5. Evaluation of imaging methods in cerebral toxoplasmosis;Polish Journal of Radiology;2023